These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8832698)

  • 1. A facile method for the labeling of proteins with zirconium isotopes.
    Meijs WE; Haisma HJ; Van der Schors R; Wijbrandts R; Van den Oever K; Klok RP; Pinedo HM; Herscheid JD
    Nucl Med Biol; 1996 May; 23(4):439-48. PubMed ID: 8832698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice.
    Meijs WE; Haisma HJ; Klok RP; van Gog FB; Kievit E; Pinedo HM; Herscheid JD
    J Nucl Med; 1997 Jan; 38(1):112-8. PubMed ID: 8998164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging.
    Perk LR; Vosjan MJ; Visser GW; Budde M; Jurek P; Kiefer GE; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):250-9. PubMed ID: 19763566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89.
    Meijs WE; Herscheid JD; Haisma HJ; Pinedo HM
    Int J Rad Appl Instrum A; 1992 Dec; 43(12):1443-7. PubMed ID: 1334954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
    Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
    J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.
    Vosjan MJ; Perk LR; Roovers RC; Visser GW; Stigter-van Walsum M; van Bergen En Henegouwen PM; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):753-63. PubMed ID: 21210114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model.
    Seo JW; Mahakian LM; Tam S; Qin S; Ingham ES; Meares CF; Ferrara KW
    Nucl Med Biol; 2015 Feb; 42(2):155-63. PubMed ID: 25451215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.
    Deri MA; Ponnala S; Kozlowski P; Burton-Pye BP; Cicek HT; Hu C; Lewis JS; Francesconi LC
    Bioconjug Chem; 2015 Dec; 26(12):2579-91. PubMed ID: 26550847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ImmunoPET imaging of tissue factor expression in pancreatic cancer with
    Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W
    J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Dias GM; Ramogida CF; Rousseau J; Zacchia NA; Hoehr C; Schaffer P; Lin KS; Bénard F
    Nucl Med Biol; 2018 Mar; 58():1-7. PubMed ID: 29291493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of
    Rousseau J; Zhang Z; Dias GM; Zhang C; Colpo N; Bénard F; Lin KS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):708-712. PubMed ID: 28131709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging.
    Shi S; Fliss BC; Gu Z; Zhu Y; Hong H; Valdovinos HF; Hernandez R; Goel S; Luo H; Chen F; Barnhart TE; Nickles RJ; Xu ZP; Cai W
    Sci Rep; 2015 Nov; 5():16930. PubMed ID: 26585551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody-Drug Conjugates: Taking Advantage of Dual Labeling with
    Muns JA; Montserrat V; Houthoff HJ; Codée-van der Schilden K; Zwaagstra O; Sijbrandi NJ; Merkul E; van Dongen GAMS
    J Nucl Med; 2018 Jul; 59(7):1146-1151. PubMed ID: 29496986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of a Zr-89-Labeled Monoclonal Antibody for Immuno-PET Imaging of Amyloid-β Deposition in the Brain.
    Fissers J; Waldron AM; De Vijlder T; Van Broeck B; Pemberton DJ; Mercken M; Van Der Veken P; Joossens J; Augustyns K; Dedeurwaerdere S; Stroobants S; Staelens S; Wyffels L
    Mol Imaging Biol; 2016 Aug; 18(4):598-605. PubMed ID: 26846128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.
    England CG; Ehlerding EB; Hernandez R; Rekoske BT; Graves SA; Sun H; Liu G; McNeel DG; Barnhart TE; Cai W
    J Nucl Med; 2017 Jan; 58(1):162-168. PubMed ID: 27493273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study.
    Radchenko V; Bouziotis P; Tsotakos T; Paravatou-Petsotas M; la Fuente Ad; Loudos G; Harris AL; Xanthopoulos S; Filosofov D; Hauser H; Eisenhut M; Ponsard B; Roesch F
    Nucl Med Biol; 2016 May; 43(5):280-7. PubMed ID: 27150030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication.
    Yokoyama A; Ohmomo Y; Horiuchi K; Saji H; Tanaka H; Yamamoto K; Ishii Y; Torizuka K
    J Nucl Med; 1982 Oct; 23(10):909-14. PubMed ID: 7119886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT.
    Walther M; Gebhardt P; Grosse-Gehling P; Würbach L; Irmler I; Preusche S; Khalid M; Opfermann T; Kamradt T; Steinbach J; Saluz HP
    Appl Radiat Isot; 2011 Jun; 69(6):852-7. PubMed ID: 21397511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ⁸⁹Zr-Labeled Versus ¹²⁴I-Labeled αHER2 Fab with Optimized Plasma Half-Life for High-Contrast Tumor Imaging In Vivo.
    Mendler CT; Gehring T; Wester HJ; Schwaiger M; Skerra A
    J Nucl Med; 2015 Jul; 56(7):1112-8. PubMed ID: 25999431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.